Cell-based flu vaccine more protective than egg-based equivalent, new data show
The results have one expert calling for a preferential recommendation for the broader population
This content has been independently produced by AusDoc, made possible through sponsorship from CSL Seqirus. The opinions expressed in this article do not necessarily reflect the sponsor’s opinion.
A veteran of Australian immunisation policy has called for an updated program recommending cell-grown influenza vaccine over the standard dose egg-grown equivalent, arguing it would result in a significant public health benefit.
